Table 3. Top candidates of differentially expressed cell-specific “common” IFN signature genes in patients with SLE and immunized healthy donors.
Affymetrix ID | Gene Symbol | CD4+ T cells (FCa) | CD16− monocytes (FC) | CD16+ monocytes (FC) | |||
SLEb | Immunized NDc | SLE | Immunized ND | SLE | Immunized ND | ||
216598_s_at | CCL2 | NSd | NS | 14.6 | 15.9 | NS | NS |
209795_at | CD69 | NS | NS | 27.3 | 8.7 | NS | NS |
219895_at | FAM70A | NS | NS | 9.2 | 5.7 | 15.5 | 3.8 |
221345_at | FFAR2 | NS | NS | 9.8 | 2.3 | 10.3 | 3.6 |
204187_at | GMPR | NS | NS | 10.2 | 7.4 | 8.5 | 5.9 |
211267_at | HESX1 | NS | NS | 16.0 | 10.0 | 6.4 | 3.3 |
202411_at | IFI27 | 47.1 | 5.6 | 37.6 | 19.4 | 33.5 | 15.2 |
214059_at | IFI44 | 3.9 | 5.3 | 6.9 | 6.8 | 10.6 | 6.3 |
204439_at | IFI44L | 17.7 | 16.4 | 13.3 | 11.2 | 22.1 | 17.7 |
203153_at | IFIT1 | 14.7 | 16.1 | 9.8 | 10.7 | 10.2 | 11.5 |
204747_at | IFIT3 | 10.4 | 12.0 | 6.1 | 7.7 | 4.4 | 5.6 |
229450_at | IFIT3 | 18.1 | 22.4 | 6.2 | 7.2 | 3.6 | 4.2 |
201601_x_at | IFITM1 | NS | NS | 15.8 | 9.9 | 5.3 | 4.7 |
214022_s_at | IFITM1 | NS | NS | 12.2 | 10.7 | 5.0 | 4.2 |
205569_at | LAMP3 | 11.0 | 9.0 | NS | NS | NS | NS |
200923_at | LGALS3BP | NS | NS | 10.9 | 5.0 | NS | NS |
226702_at | LOC129607 | 11.7 | 9.7 | 7.0 | 5.7 | 6.6 | 4.7 |
202145_at | LY6E | 20.3 | 5.0 | 27.5 | 8.3 | 10.3 | 4.0 |
202869_at | OAS1 | 11.4 | 9.2 | 3.0 | 2.9 | 2.3 | 2.0 |
205552_s_at | OAS1 | 15.1 | 9.5 | 3.3 | 3.0 | 2.1 | 2.2 |
205660_at | OASL | 6.2 | 4.1 | 11.7 | 6.9 | 13.7 | 8.4 |
213797_at | RSAD2 | 12.8 | 13.2 | 8.0 | 11.4 | 11.3 | 13.7 |
242625_at | RSAD2 | 15.0 | 12.8 | 13.4 | 12.7 | 14.3 | 14.3 |
200986_at | SERPING1 | NS | NS | 10.2 | 10.3 | 15.4 | 8.6 |
219519_s_at | SIGLEC1 | NS | NS | 24.0 | 16.6 | 165.0 | 62.5 |
44673_at | SIGLEC1 | NS | NS | 18.7 | 14.0 | 26.9 | 13.2 |
This table summarizes top candidates of differentially expressed cell-specific “common” IFN signature genes in patients with SLE and immunized healthy donors defined by a fold change ≥10 or ≤−10 in SLE.
a FC: fold change.
b Fold change (FC) by the comparison of SLE versus healthy donors (ND) before immunization.
c FC by the comparison of ND 7 days after immunization with yellow fever vaccine versus ND before immunization.
d NS: Not significant with cutoff of FC > = 2 or < = −2 in SLE.